PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

10
PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki

Transcript of PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Page 1: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

PolExGene Meeting in Paris8 February 2007

Astrid Subrizi, DDTC, University of Helsinki

Page 2: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Introduction• RPE and its functions• ARPE19 cell line as model for RPE

Objectives of UH.FP

Current experiments• Transfection with pCMV-SEAP• Intracellular distribution of Tat

peptide and list of Tat analogues to be tested

• Gelatin coated transwell system

Future plans

Page 3: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Physiologic roles of the RPE• Regeneration of bleached

visual pigments (rhodopsin)• Formation and

maintenance of the interphotoreceptor matrix and Bruch’s membrane

• Transport of fluids and ions between photoreceptors and the choriocapillaris

• Phagocytosis of shed photoreceptor outer segments

• Absorption of light and dissipation of heat energy

• …

The RPE is a central element in the pathogenesis of AMD

Page 4: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Retinal Pigment Epithelium and ARPE 19 cell line

RPE cells• are a pigmented monolayer of

cells that form the outer part of the blood/retina barrier

• have unique morphologic and functional polarity properties

• cuboidal (cross-section), hexagonal (viewed from above) monolayer of cells joined apically by tight junctions (zonula occludens).

• RPE cells are small (10 μm) in the macular region, but become flatter and broader (up to 60 μm) toward the periphery.

• average of 45 photoreceptors overly each RPE cell

ARPE 19 cell line• is a human RPE cell line

established and characterised by K.C. Dunn in 1996

• arose spontaneously and was purified until a highly epithelial culture of RPE cells with a strong growth potential was obtained

• characterization: morphology expression of biochemical

markers specific for the retina (CRALBP and RPE65)

barrier properties (TER and permeability of paracellular barrier markers)

• is an established in vitro model for the outer blood-retinal barrier

Page 5: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Objectives of UH.FP

WP 4 Preparation of plasmids and CPP-containing polyplexes

• Development of plasmids and CPP-containing polyplexes Therapeutic plasmids EBNA plasmid

• Functionalisation of polymer membranes with polyplexes

WP 5 Characterisation of polyplex-cell and polymer membrane-cell interactions

• Interaction between CPP-containing polyplexes and cells• Interaction between CIP-containing polymer membranes and cells

Page 6: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Transfection

A secreted reporter gene (SEAP) was used in order to evaluate duration and direction of the secretion of the expressed gene product.

From Mannermaa E, Curr Eye Res. 30:345–353, 2005

Transfection with PEI n/p 8

0,0

10,0

20,0

30,0

40,0

50,0

60,0

70,0

80,0

90,0

100,0

0 10 20 30 40

Days in culture after transfectionSE

AP

[ng/

h fil

ter]

Apical

Basolateral

Transfection with PEI n/p 10

0,0

50,0

100,0

150,0

200,0

250,0

0 10 20 30 40

Days in culture after transfection

SEA

P [n

g/h

filte

r]

Apical

Basolateral

Transfection with DOTAP/DOPE/PS

0,0

1000,0

2000,0

3000,0

4000,0

5000,0

6000,0

0 10 20 30 40

Days in culture after transfection

SE

AP

[n

g/h

filt

er]

Apical

Basolateral0,0

100,0

200,0

300,0

400,0

500,0

0 20 40

Summed-up SEAP secretion (μg/well):

Peak transgene expression differences:•DOTAP/DOPE/PS ~ 65 x PEI n/p 8•DOTAP/DOPE/PS ~ 25 x PEI n/p 10

Summed-up SEAP secretion (total amount):•DOTAP/DOPE/PS ~ 18 x PEI n/p 8•DOTAP/DOPE/PS ~ 12,5 x PEI n/p 10

PEI 8 PEI 10

DOTAP

Apical 11,60

16,36 272,41

Basolateral

13,01

19,10 171,07

Total 24,61

35,45 443,47

For each carrier tested, gene expression lasted for more than 40 days.

Page 7: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Intracellular distribution of Tat

Intracellular distribution of Alexa 488-Tat in dividing ARPE19 cells at 37 °C.ARPE19 cells were incubated with 1 μM or 500 nM Alexa 488-tagged Tat peptide respectively (green). Nucleus was stained with 1 μg/ml Hoechst 33258 (blue).

Page 8: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Tat-related CPPs to be checked(Dr. Maxim Antopolsky)

No. Code Sequence HPLC purity % MW calculated MW measured Amount mg

1 Tat[C1] H-CGRKKRRQRRRPPQ-OH 95 1821.3 1822.1 15

2 Tat[C1W7,8] H-CGRKKRWWRQRRRPPQ-OH 93.5 2193.8 2194.1 5

3 Tat[C1W11,12] H-CGRKKRRQRRWWRPPQ-OH 96.2 2193.8 2194.0 7

4 Tat[C1W10,11] H-CGRKKRRQRWWRRPPQ-OH 92.3 2193.8 2194.05 8

5 Tat[C1W7,8,12, 13, 15, 16] H-CGRKKRWWRQRWWRWWRPPQ-OH To be Synthesized

6 Tat[C1A7,8] H-CGRKKRAARQRRRPPQ-OH 98.2 1963.5 1964.12 10

7 Tat[C1A11,12] H-CGRKKRRQRRAARPPQ-OH 97.1 1963.5 1964.15 8

8 Tat[C1A10,11] H-CGRKKRRQRAARRPPQ-OH 95.1 1963.5 1964.16 11

9 Tat[C1A7,8,12, 13, 15, 16] H-CGRKKRAARQRAARAARPPQ-OH To be Synthesized

10 Tat[C1L7,8] H-CGRKKRLLRQRRRPPQ-OH To be Synthesized

11 Tat[C1L11,12] H-CGRKKRRQRRLLRPPQ-OH To be Synthesized

12 Tat[C1L10,11] H-CGRKKRRQRLLRRPPQ-OH To be Synthesized

13 Tat[C1L7,8,12, 13, 15, 16] H-CGRKKRLLRQRLLRLLRPPQ-OH To be Synthesized

14 Tat[C1Ahx11] H-CGRKKRRQRR-Ahx-RPPQ-OH To be Synthesized

15 Tat[C1Ahx7] H-CGRKKR-Ahx-RQRRRPPQ-OH To be Synthesized

16 Tat[C1Ahx10] H-CGRKKRRQR-Ahx-RRPPQ-OH To be Synthesized

17 Tat[C1Ahx7,11,13] H-CGRKKR-Ahx-RQR-Ahx-R-Ahx-RPPQ-OH

To be Synthesized

All peptides are synthesized employing standard Fmoc- solid phase peptide synthesis on Wang resin, purified by RP C18 semi-preparative HPLC, characterized by MS-spectrometry and available at 5-10 mg scale.

Page 9: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Gelatin coated transwell system (from UGent)

• ARPE19 cells were seeded (750’000 cells/filter) on gelatin coated transwells

• Hydrogel is composed of 10 wt% gelatin type B Synthesis: polymerization

of methacrylamide modified gelatin using e-beam

• Sample thickness is 2-3 mm

Gels cracked. Possible under-cooling during transport.

Page 10: PolExGene Meeting in Paris 8 February 2007 Astrid Subrizi, DDTC, University of Helsinki.

Future plans

• Characterization of ARPE19 cells grown on polymer matrixBiochemical differentiation (CRALBP and RPE65)Barrier properties (TER and paracellular

permeability)

• Transfection of ARPE19 cellsEBNA plasmid (self-replicating plasmid for

prolonged transfection), from Ark TherapeuticsComparison of transfection efficiency in dividing,

non differentiated cells, vs. differentiated cells